Concepedia

Min Ren

MR

Statistics

Publications

43

Citations

7.6K

H-Index

26

Active since

2005

Affiliations

Eisai (United States)(Current)

Eisai (Japan)

Kindai University

Medizinische Hochschule Hannover

National Taiwan University Hospital

Min Ren is an author at Eisai (United States) specializing in medicine, pharmacology, and oncology.

ORCID

Publications per year

2005–2025

43

Publications

43

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo, Richard S. Finn, Shukui Qin et al. · The Lancet · 2018 · 5.4K citations · Full text

, , +12

A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer

Martin Schlumberger, Barbara Jarząb, Maria E. Cabanillas et al. · Clinical Cancer Research · 2015 · 247 citations · Full text

, , +12

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

R. P A Manzano, Gholam A. Peyman, Palwasha Khan et al. · British Journal of Ophthalmology · 2006 · 221 citations · Full text

, , +17

A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine‐refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment

Maria E. Cabanillas, Martin Schlumberger, Barbara Jarząb et al. · Cancer · 2015 · 188 citations · Full text

, , +17

A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma

Toyoaki Hida, Vamsidhar Velcheti, Karen L. Reckamp et al. · Lung Cancer · 2019 · 112 citations · Full text

, , +17

1–5 of 43